Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
OWA Status	Wed, 10/12/2022 - 13:23	Check:23505:drdebwiens@gmail.com:984C8AF9-2CB4-FAAB-EE17-73D373F383D4:Updating trust level from [2] to [4]		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Check:23481:michelle.hesse@ipn.com.au:B6CA33E5-2A56-A9FC-9141-5DBF61F1E200:Updating trust level from [2] to [4]		Gäst
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Email verified	Wed, 10/12/2022 - 13:23	Email verified		Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Korea		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/content/equil%C3%ADbrio-vs-burnout-durante-covid-19	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	É Amanhã! Convite Lundbeck Webinar Internacional	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en/content/new-earn-cpd-points-online-now		Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	É Amanhã! Convite Lundbeck Webinar Internacional	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Gäst

Log Type	Authored on	Log Message	Log Node	Authored by
OWA Status	Wed, 10/12/2022 - 13:23	Check:23505:drdebwiens@gmail.com:984C8AF9-2CB4-FAAB-EE17-73D373F383D4:Updating trust level from [2] to [4]		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Check:23481:michelle.hesse@ipn.com.au:B6CA33E5-2A56-A9FC-9141-5DBF61F1E200:Updating trust level from [2] to [4]		Gäst
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Email verified	Wed, 10/12/2022 - 13:23	Email verified		Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Korea		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/content/equil%C3%ADbrio-vs-burnout-durante-covid-19	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	É Amanhã! Convite Lundbeck Webinar Internacional	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en/content/new-earn-cpd-points-online-now		Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	É Amanhã! Convite Lundbeck Webinar Internacional	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Gäst

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER